Cathy Eng is the new Associate Director of Strategic Relations and Research Partnerships at Vanderbilt Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is a leader in the prevention, diagnosis and treatment of cancer. The center’s world-renowned team of experts provides an integrated, personalized and patient-centered approach to cancer care, including treatment, research, support, education and outreach.
From a wide variety of wellness programs to a leading REACH for Survivorship Clinic, patients find support from diagnosis through survivorship.
Vanderbilt-Ingram is a National Cancer Institute-designated Comprehensive Cancer Center, one of just two centers in Tennessee and 51 in the country to earn this highest distinction, and ranks in the top 10 nationwide for cancer research grant support.
Vanderbilt-Ingram Cancer Center shared on their X page:
“Exciting news! Cathy Eng has been appointed Associate Director of Strategic Relations and Research Partnerships at Vanderbilt Ingram Cancer Center. She will enhance clinical research through strategic partnerships with pharma and biotech companies.
Congratulations, Dr. Eng!”
Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology.
Dr. Eng was previously a Professor of Medical Oncology at Vanderbilt-Ingram Cancer Center Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers.
She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers. Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.
Cathy Eng shared a post on X:
“Honored to serve in this new role to continue to promote for Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Vanderbilt Hem/Onc and work with our pharma and NCI CTEP Clinical Research colleagues.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023